WebIn June 2013, Mirati Therapeutics, Inc. became the ultimate parent corporation of MethylGene Inc. and subsidiaries by a court - and shareholder-approved plan of … WebJan 24, 2024 · Benjamin's mailing address filed with the SEC is C/O MIRATI THERAPEUTICS, 3545 CRAY COURT, SAN DIEGO, CA, 92121. Insiders trading at Mirati Therapeutics Inc Over the last 10 years, insiders at Mirati Therapeutics Inc have traded over $178,719,757 worth of Mirati Therapeutics Inc stock and bought 6,251,169 units worth …
Mirati Therapeutics, Inc. Relentless Focus on Innovation
WebJul 28, 2024 · 1 Mirati Therapeutics, 3545 Cray Court, San Diego, California 92121, United States. PMID: 35833726 PMCID: PMC9340770 DOI: 10.1021/acs.jmedchem.2c00741 … WebBusiness Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410 Mirati Therapeutics, Inc. (Filer) CIK : 0001576263 (see all company filings) IRS No. : … ultralight chairs for backpacking
Mirati’s Competitors, Revenue, Number of Employees, Funding
WebMirati Therapeutics, Inc. Attention: Vincent Caralli . ... 3545 Cray Court . San Diego, CA 92121 . Dear Mr. Caralli: Please refer to your new drug application (NDA) dated December 14, 2024, received December 14, 2024, and your … WebMirati Therapeutics. 3545 Cray Court. San Diego CA 92121. United States. 858-332-3410. www.mirati.com. Sitravatinib is a spectrum-selective kinase (RTK) inhibitor that can potentially stimulate the body's immune response to fight cancer. At this time enrollment to a Mirati clinical trials with sitravatinib is the only way to receive sitravatinib. WebMirati Therapeutics, Inc.’s revenue fell -92.44% since last year same period to $5.43Mn in the Q3 2024. On a quarterly growth basis, Mirati Therapeutics, Inc. has generated 1.29% jump in its revenue since last 3-months. ... 3545 Cray Court, San Diego, CA, United States, 92121. Employees. 413. Industry. Health Technology. CEO. Charles Baum ... ultralight coffee mug